Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorogenic Acid vs Lomustine in Recurrent Glioblastoma
NCT03758014Phase 3Unknown
- Sponsor
- Sichuan Jiuzhang Biotechnology
- Start
- Nov 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chlorogenic acid in glioblastoma (GBM), sponsored by Sichuan Jiuzhang Biotechnology. Status: unknown.
02
Drugs
chlorogenic acid
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03758014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03758014.